PADI4 is detected in the blood of cancer patients and in a large array of malignant tumours whose normal tissue and benign tumour counterparts lack PADI4 expression, while metastatic tumours exhibit significantly higher PADI4 expression than the corresponding primary tumours [49,90,145]. Here, PADI4 is linked to benign neoplasm.